Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians

被引:79
|
作者
Remme, Willem J. [1 ]
McMurray, John J. V. [3 ]
Hobbs, F. D. Richard [2 ]
Cohen-Solal, Alain [4 ]
Lopez-Sendon, Jose [5 ]
Boccanelli, Alessandro [6 ]
Zannad, Faiez [7 ]
Rauch, Bernhard [8 ]
Keukelaar, Karen [1 ]
Macarie, Cezar [9 ]
Ruzyllo, Witold [10 ]
Cline, Charles [11 ]
机构
[1] Sticares Cardiovasc Res Fdn, NL-3160 AB Rhoon, Netherlands
[2] Univ Birmingham, Birmingham, W Midlands, England
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Hop Lariboisiere, F-75475 Paris, France
[5] Hosp Univ Gregorio Maranon, Madrid, Spain
[6] Osped S Giovanni Addolorata, Rome, Italy
[7] CHU Nancy, Hop Brabois, Nancy, France
[8] Inst Herzinfarktforsch, Ludwigshafen, Germany
[9] Inst Boli Cardiovasc C C Iliescu, Bucharest, Romania
[10] Natl Inst Cardiol, Warsaw, Poland
[11] Karolinska Univ Hosp, Stockholm, Sweden
关键词
heart failure; awareness; perception; Europe; guidelines; diagnosis; treatment; advice; cardiologists; internists; geriatricians; primary care physicians; ACE inhibition; beta-blockade; aldosterone antagonists; diuretics; echocardiography; heart failure nurses;
D O I
10.1093/eurheartj/ehn196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To assess awareness of heart failure (HF) management recommendations in Europe among cardiologists (C), internists and geriatricians (I/G), and primary care physicians (PCPs). Methods and results The Study group on HF Awareness and Perception in Europe (SHAPE) surveyed randomly selected C (2041), I/G (1881), and PCP (2965) in France, Germany, Italy, the Netherlands, Poland, Romania, Spain, Sweden, and the UK. Each physician completed a 32-item questionnaire about the diagnosis and treatment of HF (left ventricular ejection fraction < 40%). This report provides an analysis of HF awareness among C, I/G, and PCP. Seventy-one per cent I/G and 92% C use echocardiography, and 43% I/G and 82% C use echo-Doppler as a routine diagnostic test (both P < 0.0001). In contrast, 75% PCP use signs and symptoms to diagnose HF. Fewer I/G would use an angiotensin-converting enzyme (ACE)-inhibitor in > 90% of their patients (64 vs. 82% C, P < 0.0001), whereas only 47% PCP would routinely prescribe an ACE-inhibitor. Worsening HF was considered a risk of ACE-inhibitor therapy by 35% PCP. I/G and PCP consistently do not prescribe target ACE-inhibitor doses (P < 0.0001 vs. C). Only 39% I/G would use a beta-blocker in > 50% of their patients (vs. 73% C, P < 0.0001). Also, only 5% PCP would always, and 35% often, prescribe a beta-blocker and reach target doses in only 7-29%. Moreover, 34% PCP and 26% I/G vs. 11% C (P < 0.0001) do not start a beta-blocker in patients with mild HF, who are already on an ACE-inhibitor and are on diuretic. In mild, stable HF, 39% PCP and 18% I/G would only prescribe diuretics, vs. 7% C (P < 0.0001). In patients with worsening HF in sinus rhythm and on an optimal ACE-inhibitor, beta-blockade and diuretics, significantly more C would add spironolactone, but I/G would more often add digoxin. Conclusions Although each physician group lacks complete adherence to guideline-recommended management strategies, these are used significantly less well by I, G, and PCPs, indicating the need for education of these essential healthcare providers.
引用
收藏
页码:1739 / 1752
页数:14
相关论文
共 50 条